Skip to content

Clinical trials

Completed Phase 1 Thyroid Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thyroid Neoplasms Phase: Phase 1 Status: Completed Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20031
20041
20053
20064
20072
20081
20113
20123
20142
20151
20171
20201
20212
20223
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Memorial Sloan Kettering Cancer Center4
National Cancer Institute (NCI)4
European Organisation for Research and Treatment of Cancer - EORTC2
University of Colorado, Denver2
Valerio Therapeutics2
AHS Cancer Control Alberta1
Case Comprehensive Cancer Center1
Celgene1
Celldex Therapeutics1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thyroid Neoplasms34
Breast Neoplasms12
Thyroid Cancer, Papillary10
Adenocarcinoma, Follicular9
Head and Neck Neoplasms9
Prostatic Neoplasms9
Colorectal Neoplasms8
Lung Neoplasms8
Ovarian Neoplasms8
Pancreatic Neoplasms8

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.